Observational study / 2014
In postmenopausal women, higher plasma betaine was linked to lower colorectal cancer risk, whereas TMAO was positively associated with rectal cancer.
Researchers examined associations between baseline plasma choline metabolites and colorectal cancer risk among 835 matched case-control pairs of postmenopausal women followed for a mean of 5.2 years. Plasma betaine was inversely associated with overall colorectal cancer (OR for highest vs. lowest quartile: 0.68, 95% CI: 0.47-0.99; P trend = 0.01) and local/regional tumors (OR: 0.64, 95% CI: 0.42-0.99). The betaine:choline ratio was also inversely associated with colorectal cancer overall (OR: 0.56, 95% CI: 0.39-0.82; P trend = 0.004). Conversely, plasma TMAO was positively associated with rectal cancer (OR: 3.38, 95% CI: 1.25-9.16; P trend = 0.02) and with overall risk among women with lower plasma vitamin B12 levels.
Shows an association, not proof of cause and effect.
- Study type
- Nested case-control study
- Who was studied
- 835 matched postmenopausal women case-control pairs from the Women's Health Initiative Observational Study
- What was measured
- Risk of colorectal cancer (proximal, distal, rectal; local/regional or metastatic)
THE PAPER
Plasma choline metabolites and colorectal cancer risk in the Women's Health Initiative Observational Study.
Bae S, Ulrich CM, Neuhouser ML, Malysheva O, Bailey LB, Xiao L, Brown EC, Cushing-Haugen KL, Zheng Y, Cheng TY, Miller JW, Green R, Lane DS, Beresford SA, Caudill MA. Cancer Res, 2014.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.